Zydus Cadila supplies 30,000 COVID Kavach Elisa test kits to ICMR for free
New Delhi: Drug firm Cadila Healthcare on Thursday said the first batch of 30,000 COVID Kavach Elisa tests manufactured by its arm Zydus Diagnostics have been supplied to Indian Council of Medical Research (ICMR), free of cost.
These test kits have been manufactured in technology transfer with ICMR-NIV of Pune for surveillance purposes, Cadila Healthcare said in a filing to BSE.
Earlier, the company had partnered with ICMR to be better equipped against infectious disease outbreaks, and help people, who are at high risk, particularly in distant, remote areas of the country, the filing said.
The company has been manufacturing and marketing a range of Elisa kits for detection and surveillance of rare and neglected diseases in humans and livestock, it added.
Shares of Cadila Healthcare were trading at Rs 344 per scrip on BSE, up 1.91 per cent from its previous close.
Read also: Zydus Cadila gets USFDA tentative nod for Droxidopa Capsules
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.